Kolesterol, AI og arbeidsgiverbekymringer

Kilder

• STAT: STAT+: FDA approves Merck’s oral PCSK9 drug, a first
• Nchstats: What Is Lipfendra, the New Pill the FDA Just Approved to Lower Cholesterol Levels? - NCHStats
• Finance: Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia - Yahoo Finance
• STAT: STAT+: Medicare wants to shake up how it pays for clinical AI
• STAT: STAT+: CMS signals intent to revamp how it pays for clinical software and AI
• STAT: STAT+: Despite earnings celebration, UnitedHealth signals more financial pain for employers
• STAT: STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
• Raps: Recon: Lilly to buy psychedelic developer AtaiBeckley for up to $3.8B; FDA approves Merck’s novel cholesterol drug - RAPS
• STAT: FDA approves Merck’s oral PCSK9 drug, a first - STAT
• STAT: STAT+: Spring forward forever? Another daylight saving debate arrives in Congress

Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.